Pralidoxime chloride for UKHSA comes from Baxter Healthcare
- UK Health Security Agency
- Direct award
- 30 November 2026 to 30 November 2028
The UK Health Security Agency is buying pralidoxime chloride, an antidote, from Baxter Healthcare. The agency began by sounding out suppliers through a request for information, and only those that signed up at that stage could go further. Suppliers also had to sign a non-disclosure agreement before seeing the tender documents.
The agency awarded the contract directly in November 2026. It is a two-year contract, and extension options could take it to November 2030. No value has been published.
Contract ends November 2028
- What
- Medicines supply
- Supplier
- Baxter Healthcare
- Value
- Not published
- How it was bought
- Direct award
- Dates and next
- Nov 2026 to Nov 2028
- Option to Nov 2030